Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.

In early December 2025, Twist Bioscience launched research-grade Plasmid DNA Preps with animal origin-free and endotoxin-free options tailored to stringent preclinical study requirements. This move ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

Every Origin Character in Baldur’s Gate 3 Each Origin character has a backstory video in the character creator where you can listen to a character monologue describing where they’re coming from at the ...

For decades—yes, literally decades—it has been easy to dismiss Blue Origin as a company brimming with potential but rarely producing much of consequence. But last week the company took a tremendous ...